Nobivac Intra-Trac 3, Intranasal

CANINE ADENOVIRUS TYPE 2-PARAINFLUENZA-BORDETELLA BRONCHISEPTICA VACCINE

Modified Live Virus and Avirulent Live Culture

Nobivac Intra-Trac 3 is a specialized intranasal vaccine designed to protect dogs from key respiratory pathogens, including canine adenovirus type 2, canine parainfluenza virus, and Bordetella bronchiseptica. This formulation is ideal for use in veterinary practices, providing effective immunity through a non-invasive nasal application. This vaccine is crucial for preventing kennel cough and other respiratory illnesses in dogs 3 weeks of age or older.

Formulated with modified live virus and avirulent live cultures, Nobivac Intra-Trac 3 is thimerosal-free, ensuring a safe vaccination experience. It is intended for intranasal administration only. The vaccine should be stored at 35°F - 46°F (2°C - 8°C) and used immediately once prepared.

To prepare the vaccine, rehydrate it with the provided diluent according to the detailed instructions. Administer 0.5 mL intranasally using the enclosed applicators. This vaccine should be given to dogs at 3 weeks of age or older, with annual revaccination recommended. It is important to follow the specific guidelines for preparation and administration to avoid systemic reactions and ensure efficacy.

Key Features:

Protects against canine adenovirus type 2, parainfluenza, and Bordetella bronchiseptica.
Can be used in puppies as young as 3 weeks of age because maternal antibodies do not interfere with localized antibody response.
Duration of immunity for Bordetella bronchiseptica is at least 1 year.
Provides rapid protection beginning as early as 48 hours post-vaccination against B. bronchiseptica.
Designed for intranasal use with included applicators.
Thimerosal-free for safety.

Directions:

Hold the vaccine vial upright and remove the seal and rubber stopper.
Rehydrate live vaccine to desired volume with the accompanying Sterile Diluent.*
Draw the vaccine back into the syringe.
Remove needle from syringe.
Apply nasal applicator tip to syringe.
Administer intranasally into one or both nostrils of the dog.

*Standard dose is 1 mL administered intranasally. Vaccine may be rehydrated with less than 1 mL of diluent to minimize discomfort when vaccinating small dogs and puppies. For one 1 mL dose, rehydrate vaccine with 1 mL sterile diluent or for one 0.5 mL dose, rehydrate vaccine with 0.5 mL sterile diluent.

Cautions/Warnings:

1. For intranasal use only. Do not inject. Systemic reactions from inadvertent injection may include vomiting, diarrhea, and lethargy. 2. Store between 2°C - 7°C (35°F - 45°F) and use immediately after reconstitution. 3. Contains preservatives: penicillin, streptomycin, and nystatin. 4. Dispose of unused vaccine properly by burning the container and contents.

Follow your veterinarian’s advice for an appropriate vaccination schedule and care. Contact Customer Service for more details or for prescription requirements.

View manufacturer and/or label information

West Nile Innovator

West Nile Innovator Vaccine

Customer Reviews

Country

Country

Compare products